Critical Comparison: Immune Therapeutics (OTCMKTS:IMUN) versus COSCIENS Biopharma (NASDAQ:CSCI)
Institutional and Insider Ownership 0.7% of COSCIENS Biopharma shares are owned by institutional investors. 0.1% of COSCIENS Biopharma shares are owned by company insiders. Comparatively, 50.6% of Immune Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for […]
Institutional and Insider Ownership 0.7% of COSCIENS Biopharma shares are owned by institutional investors. 0.1% of COSCIENS Biopharma shares are owned by company insiders. Comparatively, 50.6% of Immune Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for […]
